UK to appoint director to boost NHS use of new drugs innovation
The UK pharma trade body has backed the UK government's creation of a senior post to encourage use of the latest health technology, including drugs by the National Health Service.
In a late Monday statement, the Association of the British Pharmaceutical Industry (ABPI) welcomed the creation of the director general of innovation, growth and technology post at the Department of Health.
Junior health minister Lord Howe announced the post in a speech at the ABPI's conference last week and whoever is appointed will oversee the department's Medicines, Pharmacy and Industry Division.
The post is due to be filled in the summer, according to the ABPI, which has long been campaigning for more use of innovative medicines in NHS organisations.
Its chief executive Stephen Whitehead said in a statement:
"When the strategy for UK Life Sciences was published in December 2011, the government made a commitment to make the UK a global leader in the life sciences sector, and earlier this year the ABPI called on the government to provide greater leadership and accept a growing accountability in the development of the life sciences sector. This appointment will contribute to meeting these objectives."